BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19778991)

  • 1. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
    Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
    Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
    Lee IF; Qin H; Priatel JJ; Tan R
    Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.
    Nikoopour E; Schwartz JA; Huszarik K; Sandrock C; Krougly O; Lee-Chan E; Singh B
    J Immunol; 2010 May; 184(9):4779-88. PubMed ID: 20363968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
    Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
    J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
    Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
    Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice].
    Wang XX; Niu XH; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):105-7. PubMed ID: 12575330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
    Xia J; Liu W; Hu B; Tian Z; Yang Y
    Clin Immunol; 2010 Feb; 134(2):130-9. PubMed ID: 19875339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.
    Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B
    Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.
    Shehadeh NN; LaRosa F; Lafferty KJ
    J Autoimmun; 1993 Jun; 6(3):291-300. PubMed ID: 8397713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.